Martin Lagging

Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype

Ranjit Ray, Martin Lagging, Keith Meyer et al. · Journal of Virology · 1996 · 407 citations · Full text

Medicine, Molecular Biology, Oncology +17

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial

Eric Lawitz, Edward Gane, Brian L. Pearlman et al. · The Lancet · 2014 · 300 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

Johan Westin, Hans Nordlinder, Martin Lagging et al. · Journal of Hepatology · 2002 · 277 citations

Medicine, Infectious Diseases, Pathology +16

Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein

Ratna B. Ray, Martin Lagging, Keith Meyer et al. · Virus Research · 1995 · 254 citations

Life Sciences, Genetics, Molecular Biology +16

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

Martin Lagging, Ana I. Romero, Johan Westin et al. · Hepatology · 2006 · 213 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17